Skip to content
Screener

Teleflex TFX Stock-Based Comp

Stock-Based Comp at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58M+41.5%
Haemonetics logo
HaemoneticsHAE
$9.31M0.0%
Utah Medical Products logo
Utah Medical ProductsUTMD
$120K+46.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$8.96M-1.3%
ICU Medical logo
ICU MedicalICUI
$11.87M-17.9%
Boston Scientific logo
Boston ScientificBSX
$83M+12.2%

Other financials

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation

See full
Market cap$6.15B+24.1%
Enterprise value$8.81B+31.7%
P/S2.7×-0.1×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity+0.6×
Current ratio2.6×+0.2×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Teleflex’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 3:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000096943-26-000095
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 29, 2025
Deferred financing costs and debt discount amortization expense2,9761,705
Loss on extinguishment of debt1,150
Changes in contingent consideration(2,699)14,080
Stock-based compensation12,18212,287
Asset impairment charge8,117
Gain on non-designated foreign currency forward contracts(83,532)
Deferred income taxes, net(16,090)(1,935)
Interest benefit on swaps designated as net investment hedges(15,422)(7,484)

Item 1. Financial Statements (Unaudited):

FAQ

What is Teleflex's stock-based comp?
Teleflex (TFX) reported stock-based comp of $5.44M in Q2 2026.
How has Teleflex's stock-based comp changed year-over-year?
Teleflex's stock-based comp decreased by 3.8% year-over-year, from $5.66M to $5.44M.
What is the long-term trend for Teleflex's stock-based comp?
Over 4 years (2021 to 2025), Teleflex's stock-based comp has grown at a 2.9% compound annual growth rate (CAGR), from $22.94M to $25.7M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Teleflex's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude